Raia Drogasil S.A. (BVMF:RADL3)
Brazil
· Delayed Price · Currency is BRL 19.99
+0.51 (2.62%)
Apr 3, 2025, 1:09 PM GMT-3
Raia Drogasil Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 38,864 | 33,974 | 29,067 | 24,127 | 20,067 | Upgrade
|
Revenue Growth (YoY) | 14.39% | 16.88% | 20.48% | 20.23% | 14.24% | Upgrade
|
Cost of Revenue | 27,315 | 23,766 | 20,234 | 16,921 | 14,176 | Upgrade
|
Gross Profit | 11,550 | 10,207 | 8,834 | 7,206 | 5,891 | Upgrade
|
Selling, General & Admin | 9,195 | 8,193 | 7,056 | 5,879 | 4,936 | Upgrade
|
Other Operating Expenses | - | -147.8 | -82.57 | - | - | Upgrade
|
Operating Expenses | 9,195 | 8,045 | 6,973 | 5,879 | 4,936 | Upgrade
|
Operating Income | 2,355 | 2,162 | 1,860 | 1,327 | 955.39 | Upgrade
|
Interest Expense | -822.09 | -744.7 | -564.42 | -320.32 | -287.31 | Upgrade
|
Interest & Investment Income | 444.59 | 428.74 | 28.29 | 9.58 | 5.32 | Upgrade
|
Earnings From Equity Investments | 1.07 | -12.51 | -0.82 | -1.13 | -7.87 | Upgrade
|
Other Non Operating Income (Expenses) | -555.6 | -547.83 | -109.98 | -68.47 | -17.63 | Upgrade
|
EBT Excluding Unusual Items | 1,423 | 1,286 | 1,213 | 946.61 | 647.91 | Upgrade
|
Merger & Restructuring Charges | -9.72 | 0.86 | -28.35 | -23.41 | -5.04 | Upgrade
|
Gain (Loss) on Sale of Investments | -11.29 | -9.28 | -7.76 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | 0.23 | Upgrade
|
Asset Writedown | - | - | - | - | -11.42 | Upgrade
|
Legal Settlements | -1.12 | -60.96 | 15.94 | 64.24 | 3.42 | Upgrade
|
Other Unusual Items | 14.82 | - | - | -0.17 | -18.72 | Upgrade
|
Pretax Income | 1,416 | 1,217 | 1,193 | 987.26 | 616.37 | Upgrade
|
Income Tax Expense | 206.51 | 129.55 | 178.24 | 223.13 | 120.84 | Upgrade
|
Earnings From Continuing Operations | 1,209 | 1,087 | 1,015 | 764.13 | 495.53 | Upgrade
|
Minority Interest in Earnings | -11.51 | -32.17 | -18.86 | -12.2 | -11.09 | Upgrade
|
Net Income | 1,198 | 1,055 | 996.11 | 751.93 | 484.44 | Upgrade
|
Net Income to Common | 1,198 | 1,055 | 996.11 | 751.93 | 484.44 | Upgrade
|
Net Income Growth | 13.53% | 5.91% | 32.47% | 55.22% | -37.27% | Upgrade
|
Shares Outstanding (Basic) | 1,649 | 1,695 | 1,714 | 1,715 | 1,715 | Upgrade
|
Shares Outstanding (Diluted) | 1,655 | 1,695 | 1,720 | 1,720 | 1,720 | Upgrade
|
Shares Change (YoY) | -2.37% | -1.43% | -0.01% | 0.02% | 0.12% | Upgrade
|
EPS (Basic) | 0.73 | 0.62 | 0.58 | 0.44 | 0.28 | Upgrade
|
EPS (Diluted) | 0.72 | 0.62 | 0.58 | 0.44 | 0.28 | Upgrade
|
EPS Growth | 16.29% | 7.45% | 32.48% | 55.20% | -37.34% | Upgrade
|
Free Cash Flow | 1,500 | 480.75 | 493.34 | 701.34 | 800.82 | Upgrade
|
Free Cash Flow Per Share | 0.91 | 0.28 | 0.29 | 0.41 | 0.47 | Upgrade
|
Dividend Per Share | - | 0.212 | - | - | - | Upgrade
|
Gross Margin | 29.72% | 30.04% | 30.39% | 29.87% | 29.36% | Upgrade
|
Operating Margin | 6.06% | 6.37% | 6.40% | 5.50% | 4.76% | Upgrade
|
Profit Margin | 3.08% | 3.10% | 3.43% | 3.12% | 2.41% | Upgrade
|
Free Cash Flow Margin | 3.86% | 1.42% | 1.70% | 2.91% | 3.99% | Upgrade
|
EBITDA | 3,061 | 2,815 | 2,466 | 1,890 | 1,472 | Upgrade
|
EBITDA Margin | 7.88% | 8.29% | 8.48% | 7.83% | 7.33% | Upgrade
|
D&A For EBITDA | 706.05 | 652.77 | 605.49 | 563.46 | 516.6 | Upgrade
|
EBIT | 2,355 | 2,162 | 1,860 | 1,327 | 955.39 | Upgrade
|
EBIT Margin | 6.06% | 6.37% | 6.40% | 5.50% | 4.76% | Upgrade
|
Effective Tax Rate | 14.59% | 10.65% | 14.94% | 22.60% | 19.60% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.